← The library

Abaloparatide (Tymlos)

GI/Bone/Other
Evidence grade
AFDA-approved Rx (labeled use)
Cardiovascular · 0–5 · separate axis
1
PurposeBone
MechanismPTHrP analog: anabolic bone agent
EffectsPTHrP analog: anabolic bone agent
DosingNo human dose established.
Bottom lineStrongest data when used for its labeled indication under clinician guidance.
Batches on filenone

No tested batches on file.

Read with10
Cautions & interactions

Hypercalcemia; osteosarcoma warning in animals

Monitor calcium/vitamin D; caution with digoxin (hypercalcemia can increase toxicity risk).

CV 1 of 5 — No solid direct cardiovascular outcomes evidence; any benefit is indirect or unproven.